— Know what they know.
Not Investment Advice
Also trades as: 4506.T (JPX) · $vol 41M · DNPUF (OTC) · $vol 0M

SMDPY Earnings

Sumitomo Pharma Co., Ltd.
1W: -1.1% 1M: +11.1% 3M: +11.7% YTD: -9.8% 1Y: -6.1%
$10.32
-0.12 (-1.20%)
 
Weekly Expected Move ±7.5%
$9 $10 $10 $11 $12
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 69 · $4.6B mcap · 238M float · 0.0004% daily turnover · Short 100% of daily vol
Last Earnings 2026-05-11
EPS
¥-0.01 (US$-0.00)
▼ Miss +0.0%
Revenue
¥673M ($4M)
▲ Beat +8.1%
Next Earnings Qtr ending 2026-12-30 · date TBD
Revenue Estimate
¥174.4B ($1.1B)
3 analysts
1 USD = 157.83 JPY

Estimate vs Actual

Earnings Surprise History

0/20
EPS Beats
4/20
Revenue Beats
0%
EPS Beat Rate
20%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-14 annual 2028-03-31 ¥— ¥— — ¥612,155,057,140 ¥615,087,928,570
2026-09-14 annual 2027-03-31 ¥— ¥— — ¥561,382,885,710 ¥563,242,771,430
2026-08-31 annual 2028-03-31 ¥— ¥— — ¥609,355,057,140 ¥612,155,057,140
2026-08-31 annual 2027-03-31 ¥— ¥— — ¥558,612,171,430 ¥561,382,885,710
2026-08-28 annual 2028-03-31 ¥— ¥— — ¥602,497,914,290 ¥609,355,057,140
2026-08-28 annual 2027-03-31 ¥— ¥— — ¥554,755,028,570 ¥558,612,171,430
2026-08-28 quarter 2026-12-30 ¥— ¥— — ¥174,650,000,000 ¥174,366,666,670
2026-08-28 quarter 2026-09-30 ¥— ¥— — ¥128,600,000,000 ¥126,601,666,670
2026-08-26 annual 2028-03-31 ¥— ¥— — ¥599,069,342,860 ¥602,497,914,290
2026-08-26 annual 2027-03-31 ¥— ¥— — ¥551,726,457,140 ¥554,755,028,570
2026-08-26 quarter 2026-12-30 ¥— ¥— — ¥177,650,000,000 ¥174,650,000,000
2026-08-26 quarter 2026-09-30 ¥— ¥— — ¥119,000,000,000 ¥128,600,000,000
2026-08-07 annual 2028-03-31 ¥— ¥— — ¥597,055,057,140 ¥599,069,342,860
2026-08-07 annual 2027-03-31 ¥— ¥— — ¥548,555,028,569 ¥551,726,457,140
2026-08-04 quarter 2025-03-30 ¥— ¥— — ¥12,785,208,940,181 ¥87,911,333,330
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms